NCT07558603
Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist
Not Yet Recruiting
NAAges 45–65InterventionalTreatmentGoldman, Butterwick, Fitzpatrick and GroffInvestigator-initiated
~50 participants
Updated 2026-04-30 on ClinicalTrials.gov
What's tested:On GLP1 plus HRTOn GLP1 Only
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Modified Griffith Scale
Measured over Baseline, Week 6 and Week12
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Modified Griffith ScaleBaseline, Week 6 and Week12
Modified Griffiths 10-point scale to be used for investigator grading of cutaneous signs of photoaging on the face. Global Fine Lines. Scale 0 (no fine lines) to 9 (numerous, many fine lines) Overall Hyperpigmentation: Scale 0 (no hyperpigmentation) to 9 (significant hyperpigmentation) Skin Tone Eveness: Scale 0 (very even tone) to 9 (uneven, discolored appearance) Skin Elasticity: Score 0 (skin feels toned and dense) to 9 (skin feels thin and flabby) Skin Firmness: Score 0 (firm, tight feeling) to 9 (loose, lax feeling) Skin Radiance: Score 0 (very radiant, luminous, glowing) to 9 (very dull) Skin Texture: Score 0 (very smooth) to 9 (very rough)